Biotech Blues Could Continue

Recently, biotechnology stocks and related exchange traded funds gave back all of their gains this year and then some as political posturing, among other factors, punished the once hot sector. Bespoke Investment Group pointed out that the recent biotech pullback was not the first time the sector...